{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:25Z","timestamp":1793332465352,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["Award No-09\/1051(0029)\/2 019-EMR-1"],"award-info":[{"award-number":["Award No-09\/1051(0029)\/2 019-EMR-1"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["NCD\/Adhoc\/139\/2020-21"],"award-info":[{"award-number":["NCD\/Adhoc\/139\/2020-21"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DST-FIST","award":["SR\/FST\/LS-I\/2017\/49"],"award-info":[{"award-number":["SR\/FST\/LS-I\/2017\/49"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12035-022-02930-3","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T12:29:54Z","timestamp":1657196994000},"page":"5809-5834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Role of Omics in Migraine Research and Management: A Narrative Review"],"prefix":"10.1007","volume":"59","author":[{"given":"Pragya","family":"Chaturvedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilash","family":"Ludhiadch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4033-9124","authenticated-orcid":false,"given":"Anjana","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"2930_CR1","doi-asserted-by":"crossref","unstructured":"Ashina M et al (2021) Migraine: epidemiology and systems of care. The Lancet 397(10283):1485\u20131495","DOI":"10.1016\/S0140-6736(20)32160-7"},{"key":"2930_CR2","doi-asserted-by":"crossref","unstructured":"Eigenbrodt AK et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501\u2013514","DOI":"10.1038\/s41582-021-00509-5"},{"issue":"1","key":"2930_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"M Arnold","year":"2018","unstructured":"Arnold M (2018) Headache classification committee of the international headache society (IHS) the international classification of headache disorders. Cephalalgia 38(1):1\u2013211","journal-title":"Cephalalgia"},{"issue":"8","key":"2930_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK et al (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501\u2013514","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"2930_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1468-2982.1992.1204221.x","volume":"12","author":"BK Rasmussen","year":"1992","unstructured":"Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia 12(4):221\u2013228","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"2930_CR6","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.4103\/0972-2327.99993","volume":"15","author":"PJ Goadsby","year":"2012","unstructured":"Goadsby PJ (2012) Pathophysiology of migraine. Ann Indian Acad Neurol 15(Suppl 1):S15","journal-title":"Ann Indian Acad Neurol"},{"issue":"4","key":"2930_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00002508-200307000-00009","volume":"19","author":"EL Spierings","year":"2003","unstructured":"Spierings EL (2003) Pathogenesis of the migraine attack. Clin J Pain 19(4):255\u2013262","journal-title":"Clin J Pain"},{"key":"2930_CR8","doi-asserted-by":"crossref","unstructured":"Dodick DW (2018) A phase-by-phase review of migraine pathophysiology. Headache: the journal of head and face pain 58: 4\u201316","DOI":"10.1111\/head.13300"},{"issue":"2","key":"2930_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/14737175.2018.1414601","volume":"18","author":"P Gazerani","year":"2018","unstructured":"Gazerani P, Cairns BE (2018) Dysautonomia in the pathogenesis of migraine. Expert Rev Neurother 18(2):153\u2013165","journal-title":"Expert Rev Neurother"},{"issue":"6123","key":"2930_CR10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1231897","volume":"339","author":"H Karatas","year":"2013","unstructured":"Karatas H et al (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339(6123):1092\u20131095","journal-title":"Science"},{"issue":"26","key":"2930_CR11","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","volume":"30","author":"X Zhang","year":"2010","unstructured":"Zhang X et al (2010) Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci 30(26):8807\u20138814","journal-title":"J Neurosci"},{"issue":"4","key":"2930_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1017\/S1464793106007081","volume":"81","author":"JM Smith","year":"2006","unstructured":"Smith JM et al (2006) Physiological studies of cortical spreading depression. Biol Rev 81(4):457\u2013481","journal-title":"Biol Rev"},{"issue":"10","key":"2930_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1468-2982.2009.01983.x","volume":"29","author":"A Charles","year":"2009","unstructured":"Charles A, Brennan K (2009) Cortical spreading depression\u2014new insights and persistent questions. Cephalalgia 29(10):1115\u20131124","journal-title":"Cephalalgia"},{"key":"2930_CR14","doi-asserted-by":"crossref","unstructured":"Ebahimzadeh K et al (2021) A comprehensive review on the role of genetic factors in the pathogenesis of migraine. J Mol Neurosci 71(10):1987\u20132006","DOI":"10.1007\/s12031-020-01788-1"},{"issue":"2","key":"2930_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/brain\/awr272","volume":"135","author":"R Nassini","year":"2012","unstructured":"Nassini R et al (2012) The \u2018headache tree\u2019 via umbellulone and TRPA1 activates the trigeminovascular system. Brain 135(2):376\u2013390","journal-title":"Brain"},{"issue":"2","key":"2930_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.bjp.0705034","volume":"138","author":"R Storer","year":"2003","unstructured":"Storer R, Akerman S, Goadsby P (2003) Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex. Br J Pharmacol 138(2):317\u2013324","journal-title":"Br J Pharmacol"},{"key":"2930_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-cellbio-101011-155833","volume":"29","author":"D Julius","year":"2013","unstructured":"Julius D (2013) TRP channels and pain. Annu Rev Cell Dev Biol 29:355\u2013384","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2930_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1749-6632.2011.06326.x","volume":"1245","author":"SD Brain","year":"2011","unstructured":"Brain SD (2011) TRPV1 and TRPA1 channels in inflammatory pain: elucidating mechanisms. Ann N Y Acad Sci 1245:36\u201337","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"2930_CR19","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1111\/j.1460-9568.2007.05882.x","volume":"26","author":"S Bang","year":"2007","unstructured":"Bang S et al (2007) Transient receptor potential A1 mediates acetaldehyde-evoked pain sensation. Eur J Neurosci 26(9):2516\u20132523","journal-title":"Eur J Neurosci"},{"issue":"2","key":"2930_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/ph12020054","volume":"12","author":"S Benemei","year":"2019","unstructured":"Benemei S, Dussor G (2019) TRP channels and migraine: recent developments and new therapeutic opportunities. Pharmaceuticals 12(2):54","journal-title":"Pharmaceuticals"},{"key":"2930_CR21","doi-asserted-by":"crossref","unstructured":"Dussor G, Cao YQ (2016) TRPM8 and migraine. Headache: The Journal of Head and Face Pain 56(9):1406\u20131417","DOI":"10.1111\/head.12948"},{"issue":"1","key":"2930_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-021-01285-9","volume":"22","author":"T Acz\u00e9l","year":"2021","unstructured":"Acz\u00e9l T et al (2021) Identification of disease-and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis. J Headache Pain 22(1):1\u201318","journal-title":"J Headache Pain"},{"issue":"1","key":"2930_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-015-0564-y","volume":"16","author":"M Luk\u00e1cs","year":"2015","unstructured":"Luk\u00e1cs M et al (2015) Dural administration of inflammatory soup or complete Freund\u2019s adjuvant induces activation and inflammatory response in the rat trigeminal ganglion. J Headache Pain 16(1):1\u201311","journal-title":"J Headache Pain"},{"issue":"4","key":"2930_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.molmed.2010.02.004","volume":"16","author":"JE Meents","year":"2010","unstructured":"Meents JE, Neeb L, Reuter U (2010) TRPV1 in migraine pathophysiology. Trends Mol Med 16(4):153\u2013159","journal-title":"Trends Mol Med"},{"issue":"11","key":"2930_CR25","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1021\/cn500083e","volume":"5","author":"G Dussor","year":"2014","unstructured":"Dussor G et al (2014) Targeting TRP channels for novel migraine therapeutics. ACS Chem Neurosci 5(11):1085\u20131096","journal-title":"ACS Chem Neurosci"},{"issue":"4","key":"2930_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/jnnp-2014-308813","volume":"86","author":"M Del Fiacco","year":"2015","unstructured":"Del Fiacco M et al (2015) TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine. J Neurol Neurosurg Psychiatry 86(4):393\u2013397","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2930_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/B978-0-12-800181-3.00012-9","volume":"74","author":"J Luo","year":"2014","unstructured":"Luo J, Hu H (2014) Thermally activated TRPV3 channels. Curr Top Membr 74:325\u2013364","journal-title":"Curr Top Membr"},{"issue":"5","key":"2930_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1177\/0333102417712719","volume":"38","author":"Y Kayama","year":"2018","unstructured":"Kayama Y et al (2018) Functional interactions between transient receptor potential M8 and transient receptor potential V1 in the trigeminal system: relevance to migraine pathophysiology. Cephalalgia 38(5):833\u2013845","journal-title":"Cephalalgia"},{"issue":"5","key":"2930_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/1531-8249(200005)47:5<614::AID-ANA9>3.0.CO;2-N","volume":"47","author":"R Burstein","year":"2000","unstructured":"Burstein R et al (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47(5):614\u2013624","journal-title":"Ann Neurol"},{"issue":"02","key":"2930_CR30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1160\/TH09-08-0517","volume":"103","author":"A Dietrich","year":"2010","unstructured":"Dietrich A, Kalwa H, Gudermann T (2010) TRPC channels in vascular cell function. Thromb Haemost 103(02):262\u2013270","journal-title":"Thromb Haemost"},{"issue":"1","key":"2930_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00424-005-1469-4","volume":"451","author":"F Qian","year":"2005","unstructured":"Qian F, Noben-Trauth K (2005) Cellular and molecular function of mucolipins (TRPML) and polycystin 2 (TRPP2). Pflugers Arch 451(1):277\u2013285","journal-title":"Pflugers Arch"},{"issue":"7","key":"2930_CR32","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1681\/ASN.V1171179","volume":"11","author":"K Hanaoka","year":"2000","unstructured":"Hanaoka K, Guggino WB (2000) cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11(7):1179\u20131187","journal-title":"J Am Soc Nephrol"},{"key":"2930_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/978-3-642-54215-2_27","volume-title":"Mammalian Transient Receptor Potential (TRP) Cation Channels","author":"M Semmo","year":"2014","unstructured":"Semmo M, K\u00f6ttgen M, Hofherr A (2014) The TRPP subfamily and polycystin-1 proteins. Mammalian Transient Receptor Potential (TRP) Cation Channels. Springer, pp 675\u2013711"},{"issue":"3","key":"2930_CR34","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12031-020-01683-9","volume":"71","author":"A Yakubova","year":"2021","unstructured":"Yakubova A et al (2021) Searching for predictors of migraine chronification: a pilot study of 1911A> G polymorphism of TRPV1 gene in episodic versus chronic migraine. J Mol Neurosci 71(3):618\u2013624","journal-title":"J Mol Neurosci"},{"issue":"1","key":"2930_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ajmg.b.32007","volume":"159","author":"O Carre\u00f1o","year":"2012","unstructured":"Carre\u00f1o O et al (2012) SNP variants within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population. Am J Med Genet B Neuropsychiatr Genet 159(1):94\u2013103","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"2930_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-59745-465-0","volume-title":"The GABA receptors","author":"SJ Enna","year":"2007","unstructured":"Enna SJ (2007) The GABA receptors. The GABA receptors. Springer, pp 1\u201321"},{"issue":"4","key":"2930_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00702-017-1834-4","volume":"125","author":"E Garc\u00eda-Mart\u00edn","year":"2018","unstructured":"Garc\u00eda-Mart\u00edn E et al (2018) Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine. J Neural Transm 125(4):689\u2013698","journal-title":"J Neural Transm"},{"key":"2930_CR38","doi-asserted-by":"crossref","unstructured":"Gotra P et al (2021) Epilepsy and migraine shared genetic and molecular mechanisms: focus on therapeutic strategies. Mol Neurobiol 58(8):3874\u20133883","DOI":"10.1007\/s12035-021-02386-x"},{"key":"2930_CR39","doi-asserted-by":"crossref","unstructured":"Puppe A, Limmroth V (2007) GABAergic drugs for the treatment of migraine. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders) 6(4):247\u2013250","DOI":"10.2174\/187152707781387305"},{"issue":"1","key":"2930_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-9-109","volume":"9","author":"F Fernandez","year":"2008","unstructured":"Fernandez F et al (2008) Investigation of gamma-aminobutyric acid (GABA) A receptors genes and migraine susceptibility. BMC Med Genet 9(1):1\u201310","journal-title":"BMC Med Genet"},{"issue":"1\u20132","key":"2930_CR41","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jns.2012.03.014","volume":"318","author":"T Chen","year":"2012","unstructured":"Chen T et al (2012) Investigation of the role of the GABRG2 gene variant in migraine. J Neurol Sci 318(1\u20132):112\u2013114","journal-title":"J Neurol Sci"},{"key":"2930_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0079-6123(06)60003-4","volume":"160","author":"T Goetz","year":"2007","unstructured":"Goetz T et al (2007) GABAA receptors: structure and function in the basal ganglia. Prog Brain Res 160:21\u201341","journal-title":"Prog Brain Res"},{"issue":"48","key":"2930_CR43","doi-asserted-by":"publisher","first-page":"40224","DOI":"10.1074\/jbc.R112.386664","volume":"287","author":"E Sigel","year":"2012","unstructured":"Sigel E, Steinmann ME (2012) Structure, function, and modulation of GABAA receptors. J Biol Chem 287(48):40224\u201340231","journal-title":"J Biol Chem"},{"key":"2930_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-1-4757-2597-1_2","volume-title":"The GABA receptors","author":"H M\u00f6hler","year":"1997","unstructured":"M\u00f6hler H et al (1997) Diversity in structure, pharmacology, and regulation of GABA A receptors. The GABA receptors. Springer, pp 11\u201336"},{"issue":"33","key":"2930_CR45","doi-asserted-by":"publisher","first-page":"10650","DOI":"10.1523\/JNEUROSCI.23-33-10650.2003","volume":"23","author":"W Wei","year":"2003","unstructured":"Wei W et al (2003) Perisynaptic localization of \u03b4 subunit-containing GABAA receptors and their activation by GABA spillover in the mouse dentate gyrus. J Neurosci 23(33):10650\u201310661","journal-title":"J Neurosci"},{"issue":"8","key":"2930_CR46","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1111\/ejn.12331","volume":"38","author":"C Fuchs","year":"2013","unstructured":"Fuchs C et al (2013) GABAA receptors can initiate the formation of functional inhibitory GABA ergic synapses. Eur J Neurosci 38(8):3146\u20133158","journal-title":"Eur J Neurosci"},{"issue":"8","key":"2930_CR47","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2174\/1568026023393453","volume":"2","author":"GA Johnston","year":"2002","unstructured":"Johnston GA (2002) Medicinal chemistry and molecular pharmacology of GABA-C receptors. Curr Top Med Chem 2(8):903\u2013913","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"2930_CR48","first-page":"18","volume":"107","author":"DR Nyholt","year":"2000","unstructured":"Nyholt DR, Curtain RP, Griffiths LR (2000) Familial typical migraine: significant linkage and localization of a gene to Xq24\u201328. Hum Genet 107(1):18\u201323","journal-title":"Hum Genet"},{"issue":"2","key":"2930_CR49","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/427521","volume":"76","author":"L Russo","year":"2005","unstructured":"Russo L et al (2005) A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes. Am J Hum Gen 76(2):327\u2013333","journal-title":"The American Journal of Human Genetics"},{"issue":"1","key":"2930_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ajmg.b.30560","volume":"147","author":"C Netzer","year":"2008","unstructured":"Netzer C et al (2008) Genetic association studies of the chromosome 15 GABA-A receptor cluster in migraine with aura. Am J Med Genet B Neuropsychiatr Genet 147(1):37\u201341","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"2930_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ajmg.b.30566","volume":"147","author":"G Oswell","year":"2008","unstructured":"Oswell G et al (2008) No association of migraine to the GABA-A receptor complex on chromosome 15. Am J Med Genet B Neuropsychiatr Genet 147(1):33\u201336","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"9","key":"2930_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074087","volume":"8","author":"M Quintas","year":"2013","unstructured":"Quintas M et al (2013) Interaction between \u03b3-aminobutyric acid A receptor genes: new evidence in migraine susceptibility. PLoS ONE 8(9):e74087","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"2930_CR53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gene.2011.08.031","volume":"490","author":"PN Plummer","year":"2011","unstructured":"Plummer PN et al (2011) Significant differences in gene expression of GABA receptors in peripheral blood leukocytes of migraineurs. Gene 490(1\u20132):32\u201336","journal-title":"Gene"},{"key":"2930_CR54","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Mart\u00edn E et al (2017) Gamma-aminobutyric acid (Gaba) receptors rho (Gabrr) gene polymorphisms and risk for migraine. Headache: J Head Face Pain 57(7):1118\u20131135","DOI":"10.1111\/head.13122"},{"issue":"7","key":"2930_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10194-012-0468-z","volume":"13","author":"S Menon","year":"2012","unstructured":"Menon S et al (2012) The human \u03bc-opioid receptor gene polymorphism (A118G) is associated with head pain severity in a clinical cohort of female migraine with aura patients. J Headache Pain 13(7):513\u2013519","journal-title":"J Headache Pain"},{"issue":"1","key":"2930_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1568026043451618","volume":"4","author":"A Janecka","year":"2004","unstructured":"Janecka A, Fichna J, Janecki T (2004) Opioid receptors and their ligands. Curr Top Med Chem 4(1):1\u201317","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"2930_CR57","first-page":"1363","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR (2011) Molecular mechanisms of opioid receptor-dependent signaling and behavior. The Journal of the American Society of Anesthesiologists 115(6):1363\u20131381","journal-title":"The Journal of the American Society of Anesthesiologists"},{"issue":"3","key":"2930_CR58","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/WCO.0000000000000311","volume":"29","author":"A Charles","year":"2016","unstructured":"Charles A, Pradhan AA (2016) Delta-opioid receptors as targets for migraine therapy. Curr Opin Neurol 29(3):314\u2013319","journal-title":"Curr Opin Neurol"},{"issue":"12","key":"2930_CR59","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/0166-2236(93)90194-Q","volume":"16","author":"T Reisine","year":"1993","unstructured":"Reisine T, Bell GI (1993) Molecular biology of opioid receptors. Trends Neurosci 16(12):506\u2013510","journal-title":"Trends Neurosci"},{"issue":"3","key":"2930_CR60","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","volume":"137","author":"FM Amin","year":"2014","unstructured":"Amin FM et al (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain 137(3):779\u2013794","journal-title":"Brain"},{"issue":"6","key":"2930_CR61","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.pain.2010.12.031","volume":"152","author":"C Gaveriaux-Ruff","year":"2011","unstructured":"Gaveriaux-Ruff C et al (2011) Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152(6):1238\u20131248","journal-title":"Pain"},{"issue":"6","key":"2930_CR62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/acn3.65","volume":"1","author":"AF DaSilva","year":"2014","unstructured":"DaSilva AF et al (2014) \u03bc-Opioid activation in the prefrontal cortex in migraine attacks\u2013brief report I. Annals of clinical and translational neurology 1(6):439\u2013444","journal-title":"Annals of clinical and translational neurology"},{"issue":"26","key":"2930_CR63","doi-asserted-by":"publisher","first-page":"11056","DOI":"10.1073\/pnas.0702413104","volume":"104","author":"TD Wager","year":"2007","unstructured":"Wager TD, Scott DJ, Zubieta J-K (2007) Placebo effects on human \u03bc-opioid activity during pain. Proc Natl Acad Sci 104(26):11056\u201311061","journal-title":"Proc Natl Acad Sci"},{"key":"2930_CR64","doi-asserted-by":"crossref","unstructured":"Linnman C et al (2018) Molecular and functional PET-fMRI measures of placebo analgesia in episodic migraine: preliminary findings. NeuroImage: Clinical 17:680\u2013690","DOI":"10.1016\/j.nicl.2017.11.011"},{"key":"2930_CR65","doi-asserted-by":"crossref","unstructured":"Jassar H et al (2019) Impact of chronic migraine attacks and their severity on the endogenous \u03bc-opioid neurotransmission in the limbic system. NeuroImage: Clinical 23:101905","DOI":"10.1016\/j.nicl.2019.101905"},{"issue":"9","key":"2930_CR66","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/bph.12591","volume":"171","author":"AA Pradhan","year":"2014","unstructured":"Pradhan AA et al (2014) \u03b4-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice. Br J Pharmacol 171(9):2375\u20132384","journal-title":"Br J Pharmacol"},{"key":"2930_CR67","doi-asserted-by":"crossref","unstructured":"Bertels Z et al (2021) A non-convulsant delta-opioid receptor agonist, KNT-127, reduces cortical spreading depression and nitroglycerin-induced allodynia. Headache: J Head Face Pain 61(1):170\u2013178","DOI":"10.1111\/head.14019"},{"issue":"3","key":"2930_CR68","first-page":"1","volume":"4","author":"HY Frank","year":"2003","unstructured":"Frank HY, Catterall WA (2003) Overview of the voltage-gated sodium channel family. Genome Biol 4(3):1\u20137","journal-title":"Genome Biol"},{"issue":"3","key":"2930_CR69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.17116\/terarkh201688332-35","volume":"88","author":"I Aksenova","year":"2016","unstructured":"Aksenova I, Burduli N (2016) Laser research library. Ter Arkh 88(3):32\u201335","journal-title":"Ter Arkh"},{"key":"2930_CR70","doi-asserted-by":"crossref","unstructured":"Catterall WA, Goldin AL, Waxman SG (2005) International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacological reviews 57(4):397\u2013409","DOI":"10.1124\/pr.57.4.4"},{"issue":"11","key":"2930_CR71","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1113\/jphysiol.2011.224204","volume":"590","author":"WA Catterall","year":"2012","unstructured":"Catterall WA (2012) Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol 590(11):2577\u20132589","journal-title":"J Physiol"},{"issue":"1","key":"2930_CR72","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/107385840100700108","volume":"7","author":"LL Isom","year":"2001","unstructured":"Isom LL (2001) Sodium channel \u03b2 subunits: anything but auxiliary. Neuroscientist 7(1):42\u201354","journal-title":"Neuroscientist"},{"issue":"13","key":"2930_CR73","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1177\/0333102414529195","volume":"34","author":"CM Weller","year":"2014","unstructured":"Weller CM et al (2014) Two novel SCN1A mutations identified in families with familial hemiplegic migraine. Cephalalgia 34(13):1062\u20131069","journal-title":"Cephalalgia"},{"issue":"6","key":"2930_CR74","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/9195","volume":"2","author":"AN Akopian","year":"1999","unstructured":"Akopian AN et al (1999) The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci 2(6):541\u2013548","journal-title":"Nat Neurosci"},{"key":"2930_CR75","doi-asserted-by":"crossref","unstructured":"Fang X et al (2002) The presence and role of the tetrodotoxin-resistant sodium channel Nav1. 9 (NaN) in nociceptive primary afferent neurons. J Neurosci 22(17):7425\u20137433","DOI":"10.1523\/JNEUROSCI.22-17-07425.2002"},{"issue":"13","key":"2930_CR76","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1212\/01.wnl.0000345393.53132.8c","volume":"72","author":"K Vahedi","year":"2009","unstructured":"Vahedi K et al (2009) Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology 72(13):1178\u20131183","journal-title":"Neurology"},{"key":"2930_CR77","doi-asserted-by":"crossref","unstructured":"Vanmolkot KR et al (2007) The novel p. L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Human mutation 28(5):522\u2013522","DOI":"10.1002\/humu.9486"},{"issue":"9483","key":"2930_CR78","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0140-6736(05)66786-4","volume":"366","author":"M Dichgans","year":"2005","unstructured":"Dichgans M et al (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. The Lancet 366(9483):371\u2013377","journal-title":"The Lancet"},{"key":"2930_CR79","doi-asserted-by":"crossref","unstructured":"Eising E and van den Maagdenberg A (2017) Hemiplegic migraine and channel disorders","DOI":"10.1016\/B978-0-12-809324-5.01969-6"},{"issue":"4","key":"2930_CR80","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1152\/physrev.00057.2009","volume":"90","author":"Z Buraei","year":"2010","unstructured":"Buraei Z, Yang J (2010) The \u03b2 subunit of voltage-gated Ca2+ channels. Physiol Rev 90(4):1461\u20131506","journal-title":"Physiol Rev"},{"key":"2930_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0461-4","volume-title":"Encyclopedia of signaling molecules","author":"S Choi","year":"2012","unstructured":"Choi S (2012) Encyclopedia of signaling molecules, vol 337. Springer, New York"},{"issue":"1","key":"2930_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neulet.2009.01.081","volume":"453","author":"M D\u2019Onofrio","year":"2009","unstructured":"D\u2019Onofrio M et al (2009) The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibility. Neurosci Lett 453(1):12\u201315","journal-title":"Neurosci Lett"},{"issue":"6154","key":"2930_CR83","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1126\/science.1243352","volume":"342","author":"M Nyblom","year":"2013","unstructured":"Nyblom M et al (2013) Crystal structure of Na+, K+-ATPase in the Na+-bound state. Science 342(6154):123\u2013127","journal-title":"Science"},{"issue":"11","key":"2930_CR84","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1517\/14728222.12.11.1403","volume":"12","author":"T Mijatovic","year":"2008","unstructured":"Mijatovic T et al (2008) Na+\/K+-ATPase \u03b1 subunits as new targets in anticancer therapy. Expert Opin Ther Targets 12(11):1403\u20131417","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"2930_CR85","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1042\/CS19970254","volume":"95","author":"T Clausen","year":"1998","unstructured":"Clausen T (1998) Clinical and therapeutic significance of the Na+, K+ pump. Clin Sci 95(1):3\u201317","journal-title":"Clin Sci"},{"issue":"3","key":"2930_CR86","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10048-020-00606-5","volume":"21","author":"TR Techlo","year":"2020","unstructured":"Techlo TR et al (2020) Familial analysis reveals rare risk variants for migraine in regulatory regions. Neurogenetics 21(3):149","journal-title":"Neurogenetics"},{"issue":"6","key":"2930_CR87","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10194-011-0392-7","volume":"12","author":"HC Cox","year":"2011","unstructured":"Cox HC et al (2011) Variants in the human potassium channel gene (KCNN3) are associated with migraine in a high risk genetic isolate. J Headache Pain 12(6):603\u2013608","journal-title":"J Headache Pain"},{"issue":"8","key":"2930_CR88","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/ejhg.2011.48","volume":"19","author":"L Ligthart","year":"2011","unstructured":"Ligthart L et al (2011) Meta-analysis of genome-wide association for migraine in six population-based European cohorts. Eur J Hum Genet 19(8):901\u2013907","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"2930_CR89","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/ng.652","volume":"42","author":"V Anttila","year":"2010","unstructured":"Anttila V et al (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22 1. Nat Genet 42(10):869","journal-title":"Nat Genet"},{"issue":"8","key":"2930_CR90","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3598","volume":"48","author":"P Gormley","year":"2016","unstructured":"Gormley P et al (2016) Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 48(8):856\u2013866","journal-title":"Nat Genet"},{"key":"2930_CR91","doi-asserted-by":"crossref","unstructured":"Hautakangas H et al (2022) Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet 54(2):152\u2013160","DOI":"10.1038\/s41588-021-00990-0"},{"issue":"3","key":"2930_CR92","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/0333102413502736","volume":"34","author":"BD Vries","year":"2014","unstructured":"Vries BD et al (2014) RNA expression profiling in brains of familial hemiplegic migraine type 1 knock-in mice. Cephalalgia 34(3):174\u2013182","journal-title":"Cephalalgia"},{"issue":"1","key":"2930_CR93","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pharep.2016.09.015","volume":"69","author":"A Sekeroglu","year":"2017","unstructured":"Sekeroglu A et al (2017) Effect of PGD2 on middle meningeal artery and mRNA expression profile of L-PGD2 synthase and DP receptors in trigeminovascular system and other pain processing structures in rat brain. Pharmacol Rep 69(1):50\u201356","journal-title":"Pharmacol Rep"},{"key":"2930_CR94","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2018.04.037","volume":"1692","author":"LJ Kogelman","year":"2018","unstructured":"Kogelman LJ et al (2018) Transcriptomic profiling of trigeminal nucleus caudalis and spinal cord dorsal horn. Brain Res 1692:23\u201333","journal-title":"Brain Res"},{"issue":"13","key":"2930_CR95","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1177\/0333102418762476","volume":"38","author":"W Renthal","year":"2018","unstructured":"Renthal W (2018) Localization of migraine susceptibility genes in human brain by single-cell RNA sequencing. Cephalalgia 38(13):1976\u20131983","journal-title":"Cephalalgia"},{"key":"2930_CR96","unstructured":"Strickland D (2012) Strickland, Dudley. Role of LRP1 in Protecting the Vasculature.\u00a0Circulation 126(suppl_21):A611\u2013A611"},{"issue":"10","key":"2930_CR97","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.1016\/j.sjbs.2021.06.028","volume":"28","author":"R Zafar","year":"2021","unstructured":"Zafar R et al (2021) PRDM16, LRP1 and TRPM8 genetic polymorphisms are risk factor for Pakistani migraine patients. Saudi Journal of Biological Sciences 28(10):5793\u20135799","journal-title":"Saudi Journal of Biological Sciences"},{"issue":"11","key":"2930_CR98","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/ejhg.2016.54","volume":"24","author":"F Matesanz","year":"2016","unstructured":"Matesanz F et al (2016) A splice variant in the ACSL5 gene relates migraine with fatty acid activation in mitochondria. Eur J Hum Genet 24(11):1572\u20131577","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"2930_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-87503-5","volume":"11","author":"LJ Kogelman","year":"2021","unstructured":"Kogelman LJ et al (2021) Changes in the gene expression profile during spontaneous migraine attacks. Sci Rep 11(1):1\u201310","journal-title":"Sci Rep"},{"issue":"5","key":"2930_CR100","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/0333102417720216","volume":"38","author":"DM LaPaglia","year":"2018","unstructured":"LaPaglia DM et al (2018) RNA-Seq investigations of human post-mortem trigeminal ganglia. Cephalalgia 38(5):912\u2013932","journal-title":"Cephalalgia"},{"issue":"11","key":"2930_CR101","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1177\/0333102419851812","volume":"39","author":"LJ Kogelman","year":"2019","unstructured":"Kogelman LJ et al (2019) Comparing migraine with and without aura to healthy controls using RNA sequencing. Cephalalgia 39(11):1435\u20131444","journal-title":"Cephalalgia"},{"key":"2930_CR102","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2147\/JPR.S305483","volume":"14","author":"S-Y Xu","year":"2021","unstructured":"Xu S-Y et al (2021) Migraine with brainstem aura accompanied by disorders of consciousness. J Pain Res 14:1119","journal-title":"J Pain Res"},{"key":"2930_CR103","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1590\/0004-282x20200005","volume":"78","author":"T Akda\u011e","year":"2020","unstructured":"Akda\u011e T, Uca AU (2020) Cystatin C as a potential biomarker to evaluate migraine. Arq Neuropsiquiatr 78:337\u2013341","journal-title":"Arq Neuropsiquiatr"},{"key":"2930_CR104","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","volume":"75","author":"D Pietrobon","year":"2013","unstructured":"Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365\u2013391","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"2930_CR105","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2302\/kjm.60.82","volume":"60","author":"K Messlinger","year":"2011","unstructured":"Messlinger K, Fischer MJ, Lennerz JK (2011) Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine. Keio J Med 60(3):82\u201389","journal-title":"Keio J Med"},{"key":"2930_CR106","doi-asserted-by":"crossref","unstructured":"Papandreou O et al (2005) Serum S100\u03b2 protein in children with acute recurrent headache: a potentially useful marker for migraine. Headache: J Head Face Pain 45(10):1313\u20131316","DOI":"10.1111\/j.1526-4610.2005.00263.x"},{"key":"2930_CR107","doi-asserted-by":"crossref","unstructured":"Teepker M et al (2009) Serum concentrations of s100b and NSE in migraine. Headache: J Head Face Pain 49(2):245\u2013252","DOI":"10.1111\/j.1526-4610.2008.01228.x"},{"issue":"1","key":"2930_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10194-018-0883-x","volume":"19","author":"MJ Lee","year":"2018","unstructured":"Lee MJ et al (2018) Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. J Headache Pain 19(1):1\u20138","journal-title":"J Headache Pain"},{"key":"2930_CR109","doi-asserted-by":"crossref","unstructured":"Santos-Lasaosa S et al (2021) Calcitonin gene\u2013related peptide in migraine: from pathophysiology to treatment. Neurolog\u00eda (English Edition)","DOI":"10.1016\/j.nrleng.2019.03.025"},{"key":"2930_CR110","doi-asserted-by":"crossref","unstructured":"Irimia P et al (2020) A case control study demonstrates an increase in plasma amylin associated with chronic migraine. Available at SSRN 3572893","DOI":"10.2139\/ssrn.3572893"},{"issue":"3","key":"2930_CR111","first-page":"511","volume":"27","author":"B Elsheikh","year":"2021","unstructured":"Elsheikh B et al (2021) The serum C-reactive protein level and monocyte count assessment among adult migraine patients. Zagazig University Medical Journal 27(3):511\u2013515","journal-title":"Zagazig University Medical Journal"},{"issue":"4","key":"2930_CR112","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s13760-020-01362-x","volume":"121","author":"G Sar\u0131cam","year":"2021","unstructured":"Sar\u0131cam G (2021) Relationship between migraine headache and hematological parameters. Acta Neurol Belg 121(4):899\u2013905","journal-title":"Acta Neurol Belg"},{"key":"2930_CR113","doi-asserted-by":"crossref","unstructured":"Yazar HO et al (2020) Evaluation of simple inflammatory blood parameters in patients with migraine. Irish J Med Sci (1971-) 189(2):677\u2013683","DOI":"10.1007\/s11845-019-02136-y"},{"key":"2930_CR114","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jocn.2020.10.046","volume":"82","author":"S Yilmaz","year":"2020","unstructured":"Yilmaz S (2020) Serum NO, S100B, NSE concentrations in migraine and their relationship. J Clin Neurosci 82:32\u201335","journal-title":"J Clin Neurosci"},{"issue":"3","key":"2930_CR115","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/ane.13365","volume":"143","author":"M G\u00f6nen","year":"2021","unstructured":"G\u00f6nen M et al (2021) S100B and neuron-specific enolase levels in episodic and chronic migraine. Acta Neurol Scand 143(3):298\u2013302","journal-title":"Acta Neurol Scand"},{"key":"2930_CR116","doi-asserted-by":"crossref","unstructured":"Riesco N et al (2020) Peripheral, interictal serum S100B levels are not increased in chronic migraine patients. Headache: The Journal of Head and Face Pain 60(8):1705\u20131711","DOI":"10.1111\/head.13919"},{"issue":"1","key":"2930_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190620","volume":"13","author":"N Yuasa","year":"2018","unstructured":"Yuasa N et al (2018) Serum apolipoprotein E may be a novel biomarker of migraine. PLoS ONE 13(1):e0190620","journal-title":"PLoS ONE"},{"issue":"9","key":"2930_CR118","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3390\/jcm10091854","volume":"10","author":"E Bellei","year":"2021","unstructured":"Bellei E et al (2021) Urinary proteomics reveals promising biomarkers in menstrually related and post-menopause migraine. J Clin Med 10(9):1854","journal-title":"J Clin Med"},{"key":"2930_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2020.113165","volume":"184","author":"E Bellei","year":"2020","unstructured":"Bellei E et al (2020) Proteomic serum profile in menstrual-related and post menopause migraine. J Pharm Biomed Anal 184:113165","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"2930_CR120","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1021\/cr300484s","volume":"113","author":"NL Kuehnbaum","year":"2013","unstructured":"Kuehnbaum NL, Britz-McKibbin P (2013) New advances in separation science for metabolomics: resolving chemical diversity in a post-genomic era. Chem Rev 113(4):2437\u20132468","journal-title":"Chem Rev"},{"issue":"4","key":"2930_CR121","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/BF00711898","volume":"16","author":"G Hoffmann","year":"1993","unstructured":"Hoffmann G et al (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 16(4):648\u2013669","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"2930_CR122","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1039\/C6MB00424E","volume":"12","author":"R Zielman","year":"2016","unstructured":"Zielman R et al (2016) Metabolomic changes in CSF of migraine patients measured with 1 H-NMR spectroscopy. Mol BioSyst 12(12):3674\u20133682","journal-title":"Mol BioSyst"},{"issue":"16","key":"2930_CR123","doi-asserted-by":"publisher","first-page":"e1899","DOI":"10.1212\/WNL.0000000000007313","volume":"92","author":"GL Onderwater","year":"2019","unstructured":"Onderwater GL et al (2019) Large-scale plasma metabolome analysis reveals alterations in HDL metabolism in migraine. Neurology 92(16):e1899\u2013e1911","journal-title":"Neurology"},{"issue":"2","key":"2930_CR124","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbrc.2017.11.203","volume":"496","author":"C Ren","year":"2018","unstructured":"Ren C et al (2018) Low levels of serum serotonin and amino acids identified in migraine patients. Biochem Biophys Res Commun 496(2):267\u2013273","journal-title":"Biochem Biophys Res Commun"},{"key":"2930_CR125","doi-asserted-by":"crossref","unstructured":"Ramadan N et al (1989) Low brain magnesium in migraine. Headache: The Journal of Head and Face Pain 29(9):590\u2013593","DOI":"10.1111\/j.1526-4610.1989.hed2909590.x"},{"issue":"12","key":"2930_CR126","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1177\/0333102410394675","volume":"31","author":"H Reyngoudt","year":"2011","unstructured":"Reyngoudt H et al (2011) 31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients. Cephalalgia 31(12):1243\u20131253","journal-title":"Cephalalgia"},{"issue":"10","key":"2930_CR127","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1468-2982.2000.00146.x","volume":"20","author":"P Sarchielli","year":"2000","unstructured":"Sarchielli P et al (2000) Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia 20(10):907\u2013918","journal-title":"Cephalalgia"},{"issue":"6","key":"2930_CR128","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10194-012-0454-5","volume":"13","author":"M Fischer","year":"2012","unstructured":"Fischer M et al (2012) Brain-derived neurotrophic factor in primary headaches. J Headache Pain 13(6):469\u2013475","journal-title":"J Headache Pain"},{"key":"2930_CR129","doi-asserted-by":"crossref","unstructured":"Perini F et al (2005) Plasma cytokine levels in migraineurs and controls. Headache: J Head Face Pain 45(7):926\u2013931","DOI":"10.1111\/j.1526-4610.2005.05135.x"},{"issue":"5","key":"2930_CR130","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10194-012-0448-3","volume":"13","author":"M de Tommaso","year":"2012","unstructured":"de Tommaso M et al (2012) Serum levels of N-acetyl-aspartate in migraine and tension-type headache. J Headache Pain 13(5):389\u2013394","journal-title":"J Headache Pain"},{"issue":"1","key":"2930_CR131","first-page":"1","volume":"17","author":"M Curto","year":"2016","unstructured":"Curto M et al (2016) Altered kynurenine pathway metabolites in serum of chronic migraine patients. J Headache Pain 17(1):1\u20137","journal-title":"J Headache Pain"},{"key":"2930_CR132","doi-asserted-by":"crossref","unstructured":"Welch K et al (1976) Biochemical comparison of migraine and stroke. Headache: J Head Face Pain 16(4):160\u2013167","DOI":"10.1111\/j.1526-4610.1976.hed1604160.x"},{"issue":"1","key":"2930_CR133","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1017\/S0317167100011161","volume":"38","author":"H Turan","year":"2011","unstructured":"Turan H et al (2011) Procalcitonin levels in migraine patients. Can J Neurol Sci 38(1):124\u2013128","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"2930_CR134","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0333102416648650","volume":"37","author":"C Pisanu","year":"2017","unstructured":"Pisanu C et al (2017) High leptin levels are associated with migraine with aura. Cephalalgia 37(5):435\u2013441","journal-title":"Cephalalgia"},{"key":"2930_CR135","doi-asserted-by":"crossref","unstructured":"Shi K, Lin W, Zhao X (2020) Identifying molecular biomarkers for diseases with machine learning based on integrative omics. IEEE\/ACM transactions on computational biology and bioinformatics","DOI":"10.1109\/TCBB.2020.2986387"},{"issue":"1","key":"2930_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-7-15","volume":"7","author":"C Wrzodek","year":"2013","unstructured":"Wrzodek C et al (2013) Precise generation of systems biology models from KEGG pathways. BMC Syst Biol 7(1):1\u201312","journal-title":"BMC Syst Biol"},{"issue":"4","key":"2930_CR137","first-page":"419","volume":"5","author":"K Arakawa","year":"2005","unstructured":"Arakawa K et al (2005) KEGG-based pathway visualization tool for complex omics data. In Silico Biol 5(4):419\u2013423","journal-title":"In Silico Biol"},{"key":"2930_CR138","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1016\/j.csbj.2021.06.030","volume":"19","author":"M Picard","year":"2021","unstructured":"Picard M et al (2021) Integration strategies of multi-omics data for machine learning analysis. Comput Struct Biotechnol J 19:3735\u20133746","journal-title":"Comput Struct Biotechnol J"},{"key":"2930_CR139","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.csbj.2020.06.006","volume":"18","author":"P Ferroni","year":"2020","unstructured":"Ferroni P et al (2020) Machine learning approach to predict medication overuse in migraine patients. Comput Struct Biotechnol J 18:1487\u20131496","journal-title":"Comput Struct Biotechnol J"},{"key":"2930_CR140","doi-asserted-by":"crossref","unstructured":"\u00c7elik U et al (2015) Diagnostic accuracy comparison of artificial immune algorithms for primary headaches. Computational and mathematical methods in medicine, 2015","DOI":"10.1155\/2015\/465192"},{"key":"2930_CR141","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1016\/j.metabol.2018.08.002","volume":"87","author":"N Perakakis","year":"2018","unstructured":"Perakakis N et al (2018) Omics, big data and machine learning as tools to propel understanding of biological mechanisms and to discover novel diagnostics and therapeutics. Metabolism-Clinical and Experimental 87:A1\u2013A9","journal-title":"Metabolism-Clinical and Experimental"},{"issue":"3","key":"2930_CR142","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1109\/MCI.2018.2840660","volume":"13","author":"A Athreya","year":"2018","unstructured":"Athreya A et al (2018) Augmentation of physician assessments with multi-omics enhances predictability of drug response: a case study of major depressive disorder. IEEE Comput Intell Mag 13(3):20\u201331","journal-title":"IEEE Comput Intell Mag"},{"issue":"2","key":"2930_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2018.e01043","volume":"5","author":"FP Bravo","year":"2019","unstructured":"Bravo FP et al (2019) Prediction of patient\u2019s response to OnabotulinumtoxinA treatment for migraine. Heliyon 5(2):e01043","journal-title":"Heliyon"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02930-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-02930-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02930-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T14:05:26Z","timestamp":1661177126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-02930-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":143,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2930"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-02930-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,7]]},"assertion":[{"value":"1 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}